Search

everythinglearnresearchcommunity

for

Search:↓

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Higher MPV and CRP levels may indicate more severe alopecia areata.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Septin4 helps kill colon cancer cells by working with the protein BAX.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The new automatic tool accurately measures hair thickness and is reliable.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document concludes that skin and nail changes can indicate various underlying health conditions.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

High DKK1 levels predict worse survival in head and neck cancer.